Safe and potent anti-CD19 CAR T-cells with shRNA-IL-6 gene silencing element in patients with refractory or relapsed B-cell acute lymphoblastic leukemia.

MLA

Ma, Jin-Feng, et al. “Safe and Potent Anti-CD19 CAR T-Cells with ShRNA-IL-6 Gene Silencing Element in Patients with Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia.” HemaSphere, vol. 8, no. 10, Oct. 2024, p. e70007. EBSCOhost, https://doi.org/10.1002/hem3.70007.

APA

Ma, J.-F., Yan, J.-W., Liu, M.-J., Yan, C.-L., Tang, X.-W., Qiu, H.-Y., Miao, M., Han, Y., Li, L.-M., Kang, L.-Q., Xu, N., Yu, Z., Tan, J.-W., Zhu, H.-J., Jia, X., Zhang, Z.-Z., Wang, M., Dai, H.-P., Yu, L., … Gong, W.-J. (2024). Safe and potent anti-CD19 CAR T-cells with shRNA-IL-6 gene silencing element in patients with refractory or relapsed B-cell acute lymphoblastic leukemia. HemaSphere, 8(10), e70007. https://doi.org/10.1002/hem3.70007

Chicago

Ma, Jin-Feng, Jia-Wei Yan, Mei-Jing Liu, Chun-Long Yan, Xiao-Wen Tang, Hui-Ying Qiu, Miao Miao, et al. 2024. “Safe and Potent Anti-CD19 CAR T-Cells with ShRNA-IL-6 Gene Silencing Element in Patients with Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia.” HemaSphere 8 (10): e70007. doi:10.1002/hem3.70007.